Nakagawa et al. [20] demonstrated that silencing of androgen–androgen receptor signaling may cause initiation and progression of seminomas through an increase in TPH1 gene expression level via the activation of androgen–androgen receptor signaling in seminoma cells. The gene discussed is AR; the disease is seminoma.